@article{Liu2026, 
author = {Shunji Liu and Jiazheng Li and Ting Li and Qinchang Zhang and Rui Wu and Tianyi Zhang and Haibo Cheng and Wen Lv and Yang Sun and Lisha Zhou},
title = {Parthenolide suppresses colorectal adenoma progression by restraining mast cell degranulation-associated epithelial remodeling},
year = {2026},
journal = {Chinese Journal of Natural Medicines},
volume = {24},
number = {12},
pages = {1509-1521},
keywords = {Colorectal adenoma, Parthenolide, Mast cell, Degranulation, Epithelial remodeling},
url = {https://www.sciopen.com/article/10.1016/S1875-5364(26)61237-X},
doi = {10.1016/S1875-5364(26)61237-X},
abstract = {Colorectal adenomas are major precursors of colorectal cancer, yet pharmacological strategies for intercepting adenoma progression remain limited. Increasing evidence suggests that immune–epithelial interactions contribute to early neoplastic remodeling; however, the role of mast cells in this process and their therapeutic relevance remain incompletely understood. This study aimed to identify potential therapeutic compounds for colorectal adenoma and to investigate the cellular and molecular mechanisms underlying their effects. Single-cell transcriptomic analysis was integrated with A Single-cell Guided Pipeline to Aid Repurposing of Drugs (ASGARD) to identify candidate compounds for colorectal adenoma. The therapeutic efficacy of parthenolide (PTL) was evaluated in ApcMin/+  mice by histopathological analyses. Single-cell RNA sequencing, epithelial subclustering, pseudotime analysis, pathway enrichment, and cell-cell communication analysis were subsequently performed to characterize PTL-associated remodeling of the adenoma microenvironment. Mast-cell activation and degranulation were further examined using cellular assays, and mast cell-epithelial interactions were investigated using conditioned medium and organoid models. ASGARD analysis prioritized PTL as a candidate compound capable of reversing adenoma-associated transcriptional alterations. PTL treatment alleviated pathological abnormalities and aberrant epithelial proliferation in ApcMin/+  mice. Single-cell analysis revealed remodeling of epithelial states during adenoma development, characterized by alterations in progenitor-like and Wnt-responsive epithelial populations, which were partially reversed following PTL treatment. Notably, adenoma progression was associated with a mast-cell transcriptional state enriched in granule-related programs. This mast-cell signature correlated with the abundance of Wnt-responsive epithelial cells, linking mast-cell activation to epithelial-state remodeling and PTL treatment attenuated these alterations. These findings identify PTL as a potential pharmacological intervention for colorectal adenoma and suggest that its therapeutic effects involve modulation of mast cell–epithelial interactions and aberrant epithelial remodeling.}
}